These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18951273)

  • 1. Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-coated liposomes of CPT-11-HCl.
    Shende P; Gaud R
    Drug Dev Ind Pharm; 2009 May; 35(5):612-8. PubMed ID: 18951273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of lipid vesicles of camptothecin as targeted drug delivery system.
    Prabhakara P; Zenia T; Marina K; Shama KP; Girish SN; Matapady NH
    Pak J Pharm Sci; 2013 Jul; 26(4):779-86. PubMed ID: 23811458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
    Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
    Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and characterization of chitosan coated puerarin liposomes].
    Wang HG; Zhai GX; Lü QZ; Ling PX
    Zhong Yao Cai; 2007 Jan; 30(1):89-92. PubMed ID: 17539312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids.
    Li X; Kong X; Zhang J; Wang Y; Wang Y; Shi S; Guo G; Luo F; Zhao X; Wei Y; Qian Z
    J Pharm Sci; 2011 Jan; 100(1):232-41. PubMed ID: 20533555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation.
    Ramsay E; Alnajim J; Anantha M; Taggar A; Thomas A; Edwards K; Karlsson G; Webb M; Bally M
    Pharm Res; 2006 Dec; 23(12):2799-808. PubMed ID: 17063397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
    Opanasopit P; Ngawhirunpat T; Chaidedgumjorn A; Rojanarata T; Apirakaramwong A; Phongying S; Choochottiros C; Chirachanchai S
    Eur J Pharm Biopharm; 2006 Nov; 64(3):269-76. PubMed ID: 16870407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra and inter-molecular interactions dictate the aggregation state of irinotecan co-encapsulated with floxuridine inside liposomes.
    Dicko A; Frazier AA; Liboiron BD; Hinderliter A; Ellena JF; Xie X; Cho C; Weber T; Tardi PG; Cabral-Lilly D; Cafiso DS; Mayer LD
    Pharm Res; 2008 Jul; 25(7):1702-13. PubMed ID: 18320294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.
    Li Z; Li X; Cao Z; Xu Y; Lin H; Zhao Y; Wei Y; Qian Z
    Oncol Rep; 2012 Apr; 27(4):1035-40. PubMed ID: 22245938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
    J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-coated nanoliposome as vitamin E carrier.
    Liu N; Park HJ
    J Microencapsul; 2009 May; 26(3):235-42. PubMed ID: 18798045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
    Tardi PG; Gallagher RC; Johnstone S; Harasym N; Webb M; Bally MB; Mayer LD
    Biochim Biophys Acta; 2007 Mar; 1768(3):678-87. PubMed ID: 17208196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric micelles of ammonium palmitoyl glycol chitosan and solubilization of camptothecin.
    Ranjha NM
    PDA J Pharm Sci Technol; 2009; 63(1):81-7. PubMed ID: 19455944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chitosan and gelatin coated microparticles: prepared by hot-melt method.
    Lin WJ; Kang WW
    J Microencapsul; 2003; 20(2):169-77. PubMed ID: 12554372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors effect on the loading efficiency of Vitamin C loaded chitosan-coated nanoliposomes.
    Liu N; Park HJ
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):16-9. PubMed ID: 19926458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.
    Refai H; Hassan D; Abdelmonem R
    Drug Deliv; 2017 Nov; 24(1):278-288. PubMed ID: 28165805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
    Lundberg BB
    Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solidification of liposomes by freeze-drying: the importance of incorporating gelatin as interior support on enhanced physical stability.
    Guan P; Lu Y; Qi J; Niu M; Lian R; Wu W
    Int J Pharm; 2015 Jan; 478(2):655-64. PubMed ID: 25510601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.